MENU
+Compare
THTX
Stock ticker: NASDAQ
AS OF
Jul 2 closing price
Price
$2.36
Change
+$0.06 (+2.61%)
Capitalization
108.47M

THTX Theratechnologies Forecast, Technical & Fundamental Analysis

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients... Show more

THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for THTX with price predictions
Jul 01, 2025

THTX's RSI Oscillator dives oversold zone

The RSI Oscillator for THTX moved into overbought territory on July 01, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where THTX advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

THTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on THTX as a result. In of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

THTX moved below its 50-day moving average on June 13, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for THTX crossed bearishly below the 50-day moving average on June 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for THTX entered a downward trend on July 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.395). P/E Ratio (0.000) is within average values for comparable stocks, (58.556). THTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.311). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.324) is also within normal values, averaging (259.528).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

THTX is expected to report earnings to fall 30.00% to -7 cents per share on October 11

Theratechnologies THTX Stock Earnings Reports
Q3'23
Est.
$-0.07
Q2'23
Missed
by $0.04
Q1'23
Missed
by $0.06
Q4'22
Missed
by $0.01
Q3'22
Est.
$-0.08
The last earnings report on July 12 showed earnings per share of -10 cents, missing the estimate of -5 cents. With 60.89K shares outstanding, the current market capitalization sits at 108.47M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUGDF52.690.46
+0.88%
Lundin Gold Inc.
AGTT0.06N/A
N/A
Angstrom Technologies, Inc.
SWPFF2.32N/A
N/A
Swire Properties Ltd.
LLEIF0.88N/A
N/A
Lleidanetworks Serveis Telematics S A
MDTWF2.15N/A
N/A
Mediterranean Towers LTD

THTX and Stocks

Correlation & Price change

A.I.dvisor tells us that THTX and IDYA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and IDYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
+2.83%
IDYA - THTX
27%
Poorly correlated
+3.79%
GNPX - THTX
27%
Poorly correlated
+0.01%
THRD - THTX
26%
Poorly correlated
+0.18%
SCPH - THTX
26%
Poorly correlated
+3.44%
CSLLY - THTX
26%
Poorly correlated
+0.56%
More